My bookmarksSign up free
Source

Commission Implementing Regulation (EU) 2026/1427 of 2 July 2026 authorising the placing on the market of egg membrane hydrolysate (enzymatically produced) as a novel food and amending Implementing Regulation (EU) 2017/2470

Commission Implementing Regulation (EU) 2026/1427 of 2 July 2026 authorising the placing on the market of egg membrane hydrolysate (enzymatically produced) as a novel food and amending Implementing Regulation (EU) 2017/2470

Implementing Regulation (EU) 2026/1427 · Regulation · 5 articles

Data as of 2026-07-30 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

1.   Egg membrane hydrolysate (enzymatically produced) is authorised to be placed on the market within the Union. Egg membrane hydrolysate (enzymatically produced) shall be included in the Union list of novel foods set out in Implementing Regulation (EU) 2017/2470. 2.   The Annex to Implementing Regulation (EU) 2017/2470 is amended in accordance with the Annex to this Regulation.

Article 2

Open ↗

Only the company Eggnovo SL  ( 13 ) is authorised to place on the market within the Union the novel food referred to in Article 1, for a period of 5 years from 23 July 2026, unless a subsequent applicant obtains an authorisation for the novel food without reference to the scientific data protected pursuant to Article 3 or with the agreement of the company Eggnovo SL.

Article 3

Open ↗

The scientific data contained in the application file and fulfilling the conditions laid down in Article 26(2) of Regulation (EU) 2015/2283 shall not be used for the benefit of a subsequent applicant for a period of 5 years from the date of entry into force of this Regulation without the agreement of the company Eggnovo SL.

Article 4

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX The Annex to Implementing Regulation (EU) 2017/2470 is amended as follows: (1) in Table 1 (Authorised novel foods) the following entry is inserted in alphabetical order: Authorised novel food Conditions under which the novel food may be used Additional specific labelling requirements Other requirements Data protection ‘ Egg membrane hydrolysate (enzymatically produced) Specified food category Maximum levels The designation of the novel food on the labelling of food supplements containing it shall be “egg membrane hydrolysate”. The labelling of food supplements containing “egg membrane hydrolysate” shall bear a statement that they should not be consumed by persons under 18 years of age, pregnant and lactating women.   Authorised on 23 July 2026. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: “Eggnovo SL”, Av. de los Tilos n° 5, 31132 Villatuerta, Navarra, Spain. During the period of data protection, the novel food egg membrane hydrolysate (enzymatically produced) is authorised for placing on the market within the Union only by “Eggnovo SL” unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of “Eggnovo SL”. End date of the data protection: 23 July 2031.’ Food supplements as defined in Directive 2002/46/EC, for the general adult population, excluding pregnant and lactating women. 500 mg/day (2) in Table 2 (Specifications), the following entry is inserted in alphabetical order: Authorised novel food Specification ‘ Egg membrane hydrolysate (enzymatically produced) Description : The novel food is a protein hydrolysate produced by enzymatic (food enzyme papain) hydrolysis of chicken ( Gallus gallus domesticus ) egg membranes. The product is a water-soluble cream-yellowish powder. Characteristics/Composition : Crude protein (% w/w): ≥ 70 Collagen (% w/w): 15-30 Moisture (% w/w): ≤ 8 Microbiological criteria : TAMC ( a ): ≤ 5 × 10 4 CFU ( b )/g TYMC ( c ): ≤ 100 CFU/g Escherichia coli: Absence in 10 g Salmonella spp.: Absence in 25 g Listeria monocytogenes : Absence in 25 g ( a ) TAMC = Total Aerobic Microbial Count; ( b ) CFU = Colony Forming Units; ( c ) TYMC = Total Yeast and Mould Count.’

Other acts of the same type
Council Regulation (EU) 2026/1805 of 16 July 2026 amending Regulation (EU) No 833/2014 concerning restrictive measures in view of Russia’s actions destabilising the situation in UkraineCommission Implementing Regulation (EU) 2026/1812 of 16 July 2026 amending for the 358th time Council Regulation (EC) No 881/2002 imposing certain specific restrictive measures directed against certain persons and entities associated with the ISIL (Da'esh) and Al-Qaida organisationsCommission Implementing Regulation (EU) 2026/1730 of 15 July 2026 amending Implementing Regulation (EU) 2025/848 as regards applicable standards and specificationsCommission Implementing Regulation (EU) 2026/1731 of 15 July 2026 amending Implementing Regulations (EU) 2024/2977, (EU) 2024/2979, (EU) 2024/2980 and (EU) 2024/2982 as regards applicable standards and specificationsCommission Implementing Regulation (EU) 2026/1735 of 15 July 2026 amending Implementing Regulation (EU) 2025/1569 as regards applicable standards and specificationsCommission Implementing Regulation (EU) 2026/1792 of 15 July 2026 on the registration of the geographical indication Mura / Murai (PDO) in the Union register of geographical indications pursuant to Regulation (EU) 2024/1143 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2026/1696 of 14 July 2026 renewing the approval of the active substance pelargonic acid in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011Commission Implementing Regulation (EU) 2026/1700 of 14 July 2026 amending Implementing Regulation (EU) 2015/1831 laying down rules for the application of Regulation (EU) No 1144/2014 of the European Parliament and of the Council on information provision and promotion measures concerning agricultural products implemented in the internal market and in the third countries, as regards the conclusion of contracts, advance payments, and notification obligationsRegulation (EU) 2026/1768 of the European Parliament and of the Council of 14 July 2026 amending Regulation (EU) 2021/2115 as regards a specific type of intervention to provide exceptional temporary support under the European Agricultural Fund for Rural Development (EAFRD) and the possibility to adapt direct payments allocations for calendar year 2027 and Regulation (EU) 2021/2116 as regards more flexible rules on payments of advances in response to the increased fertiliser prices due to the Middle East crisisCommission Implementing Regulation (EU) 2026/1565 of 13 July 2026 amending Implementing Regulation (EU) 2024/3084 as regards the submission of due diligence statements, simplified declarations for micro or small primary operators, contingency arrangements and other measures simplifying the use of the information systemCommission Implementing Regulation (EU) 2026/1566 of 13 July 2026 laying down the technical specifications of data requirements and the deadlines for submission of annual metadata and quality reports for the topic ICT usage and e-commerce for the reference year 2027, pursuant to Regulation (EU) 2019/2152 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2026/1692 of 13 July 2026 granting a Union authorisation for the biocidal product family ECA Disinfect Product family 5 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next